Organ Damage and Quality of Life in Antiphospholipid Syndrome

Current Rheumatology Reports
P AlbaM C Amigo

Abstract

Antiphospholipid syndrome (APS) affects young patients in the most productive years of their life, and the consequences of organic or tissue damage involve a decrease in health-related quality of life (HRQoL). While acute disease manifestations of APS are well known, information on the long-term prognosis and damage in affected patients is still very limited. Systemic lupus erythematosus (SLE) patients would be expected to experience long-term complications and even die as a consequence of APS. Organ damage in APS has been evaluated using different methods and definitions, including the SLICC/ACR Damage Index (SDI), which tend to underestimate aPL-related damage. A new damage index in APS has been proposed (DIAPS), and it seems to be more accurate than SDI. Given the implications for morbidity and mortality, it is imperative to assess accurately aPL-related damage and HRQoL in patients with APS.

References

Aug 15, 1992·Annals of Internal Medicine·M H Rosove, P M Brewer
Aug 5, 2000·QJM : Monthly Journal of the Association of Physicians·M G TektonidouH M Moutsopoulos
Apr 16, 2002·Arthritis and Rheumatism·Ricard CerveraUNKNOWN Euro-Phospholipid Project Group
May 22, 2003·Annals of the Rheumatic Diseases·D ErkanUNKNOWN Catastrophic Antiphospholipid Syndrome Registry Project Group
Aug 2, 2003·Lupus·R A AshersonUNKNOWN Catastrophic Antiphospholipid Syndrome Registry Project Group
Sep 12, 2003·Current Rheumatology Reports·Ronald A Asherson, Ricard Cervera
May 14, 2004·Annals of the Rheumatic Diseases·H S J Picavet, N Hoeymans
May 14, 2004·Annals of the Rheumatic Diseases·G EspinosaR A Asherson
Feb 15, 2005·Annals of the Rheumatic Diseases·R CerveraUNKNOWN Catastrophic Antiphospholipid Syndrome Registry Project Group
Jul 27, 2006·Arthritis and Rheumatism·Silvia BucciarelliUNKNOWN European Forum on Antiphospholipid Antibodies
Jan 16, 2007·Annals of the Rheumatic Diseases·José A Gómez-PuertaJosep Font
Mar 6, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Marie MartinTracy Li
Jan 22, 2008·Seminars in Arthritis and Rheumatism·Ronald A AshersonYehuda Shoenfeld
Nov 18, 2008·The Journal of Perinatal & Neonatal Nursing·Susan MathewLene Symes
Mar 28, 2009·Journal of Autoimmunity·Ricard CerveraUNKNOWN Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum On Antiphospholipid Antibodies)
Mar 3, 2011·The Journal of Rheumatology·Amaris K BalitskyPaul R Fortin
Jun 2, 2011·Annals of the Rheumatic Diseases·José Antonio Vargas-HitosMunther A Khamashta
Jan 17, 2012·The Journal of Rheumatology·Eleftheria P GrikaPanayiotis G Vlachoyiannopoulos
Jul 13, 2012·Seminars in Arthritis and Rheumatism·Gerard EspinosaUNKNOWN Catastrophic Antiphospholipid Syndrome (CAPS) Registry Project Group (European Forum on Antiphospholipid Antibodies)
Jan 28, 2014·Annals of the Rheumatic Diseases·R CerveraUNKNOWN Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies)
Mar 26, 2014·PloS One·Lukas A HolzerGerold Holzer
Apr 4, 2015·BMJ : British Medical Journal·Tracy JallowHeidi Lempp
Apr 9, 2015·European Journal of Clinical Investigation·Mira MerashliMunther Khamashta
Apr 12, 2015·Lupus·S ZuilyUNKNOWN TAC(I)T investigators
Apr 25, 2015·Thrombosis Journal·Mario BazzanFabio Marletto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.